לוג'וקסטה 10 מג ישראל - עברית - Ministry of Health

לוג'וקסטה 10 מג

medison pharma ltd - lomitapide as mesylate - קפסולות - lomitapide as mesylate 10 mg - lomitapide

לוג'וקסטה 20 מג ישראל - עברית - Ministry of Health

לוג'וקסטה 20 מג

medison pharma ltd - lomitapide as mesylate - קפסולות - lomitapide as mesylate 20 mg - lomitapide

לוג'וקסטה 5 מג ישראל - עברית - Ministry of Health

לוג'וקסטה 5 מג

medison pharma ltd - lomitapide as mesylate - קפסולות - lomitapide as mesylate 5 mg - lomitapide

דואודרט ישראל - עברית - Ministry of Health

דואודרט

glaxo smith kline (israel) ltd - dutasteride; tamsulosin hydrochloride - קפסולות - dutasteride 0.5 mg; tamsulosin hydrochloride 0.4 mg - tamsulosin - tamsulosin - treatment of moderate to severe symptoms of benign prostatic hyperplasia (bph). reduction in the risk of acute urinary retention (aur) and surgery in patients with moderate to severe symptoms of bph.

טובי תמיסה לשאיפה ישראל - עברית - Ministry of Health

טובי תמיסה לשאיפה

dexcel ltd, israel - tobramycin - תמיסה לשאיפה - tobramycin 300 mg / 5 ml - tobramycin - tobramycin - for the management of cystic fibrosis patients with pseudomonas aeruginosa.

סנדאימון   ניאורל   25 מג כמוסות ישראל - עברית - Ministry of Health

סנדאימון ניאורל 25 מג כמוסות

novartis israel ltd - ciclosporin - קפסולות - ciclosporin 25 mg - cyclosporin - cyclosporin - prophylaxis of organ rejection in kidney liver heart allogenic transplants in conjunction with corticosteroids. may also be used in the treatment of chronic rejection in patients previously treated with other immuno-suppressive agents. bone marrow transplantation. endogenous uveitis. severe psoriasis above age 16 that did not respond to other treatment. atopic dermatitis in adults only up to 8 weeks for severe cases in which conventional therapy is ineffective or inappropriate. rheumatoid arthritis: severe cases in which standard treatments are ineffective or inappropriate. nephrotic syndrom type mcd (minimal change disease) in cases where conventional therapy has failed.

סנדאימון   ניאורל   50 מג כמוסות ישראל - עברית - Ministry of Health

סנדאימון ניאורל 50 מג כמוסות

novartis israel ltd - ciclosporin - קפסולות - ciclosporin 50 mg - cyclosporin - cyclosporin - prophylaxis of organ rejection in kidney liver heart allogenic transplants in conjunction with corticosteroids. may also be used in the treatment of chronic rejection in patients previously treated with other immuno-suppressive agents. bone marrow transplantation. endogenous uveitis. severe psoriasis above age 16 that did not respond to other treatment. atopic dermatitis in adults only up to 8 weeks for severe cases in which conventional therapy is ineffective or inappropriate. rheumatoid arthritis: severe cases in which standard treatments are ineffective or inappropriate. nephrotic syndrom type mcd (minimal change disease) in cases where conventional therapy has failed.

סנדאימון   ניאורל   100 מג כמוסות ישראל - עברית - Ministry of Health

סנדאימון ניאורל 100 מג כמוסות

novartis israel ltd - ciclosporin - קפסולות - ciclosporin 100 mg - cyclosporin - cyclosporin - prophylaxis of organ rejection in kidney liver heart allogenic transplants in conjunction with corticosteroids. may also be used in the treatment of chronic rejection in patients previously treated with other immuno-suppressive agents. bone marrow transplantation. endogenous uveitis. severe psoriasis above age 16 that did not respond to other treatment. atopic dermatitis in adults only up to 8 weeks for severe cases in which conventional therapy is ineffective or inappropriate. rheumatoid arthritis: severe cases in which standard treatments are ineffective or inappropriate. nephrotic syndrom type mcd (minimal change disease) in cases where conventional therapy has failed.

טרובלט 50 מ"ג , טרובלט 100 מ"ג ישראל - עברית - Ministry of Health

טרובלט 50 מ"ג , טרובלט 100 מ"ג

glaxo smith kline (israel) ltd - retigabine 100 mg; retigabine 50 mg - film coated tablets - retigabine - trobalt is indicated as adjunctive treatment of drug-resistant partial onset seizures with or without secondary generalization in patients aged 18 -65 years with epilepsy, where other appropriate drug combinations have proved inadequate or have not been tolerated.

ז'נס אנטי אייג'ינג קפסולות ישראל - עברית - Ministry of Health

ז'נס אנטי אייג'ינג קפסולות

בי.פור.יו בעמ - צמצום קמטים וקמטוטים